回顾主要癌症疗法:病毒疗法在癌症治疗中大有可为

Amirhossein Rismanbaf
{"title":"回顾主要癌症疗法:病毒疗法在癌症治疗中大有可为","authors":"Amirhossein Rismanbaf","doi":"10.18502/igj.v5i1.14065","DOIUrl":null,"url":null,"abstract":"In 2020, around 10 million deaths worldwide were attributed to cancer, making it one of the leading causes of mortality globally. On the other hand, a lot of money, time, and energy is spent on the treatment process of this disease. In fact, cancer is a big challenge that we have been facing for years, but there is still no method that can definitively cure this disease. For years, we have mainly used surgery, chemotherapy, and radiation therapy to treat cancer. Although many advances have been made in these methods, these methods are not a definitive cure for all types of cancer and also have many complications and impose high costs on patients. By virtue of the remarkable effectiveness of CAR-T cell therapy in the treatment of leukemia, hopes for effective treatment for various types of cancer increased, but by testing this method in solid tumors, it was found that this method has low efficiency in solid tumors. In this review article, I consider the challenges and mechanisms that cancer cells apply to resist different main therapies, and finally, by comparing the challenges of different therapies, I conclude that virus therapy has a higher potential than other methods to end the problem of cancer and become a definitive cure for cancer.","PeriodicalId":406184,"journal":{"name":"Immunology and Genetics Journal","volume":"6 3","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Reviewing the Main Cancer Therapies: Virotherapy Has a High Potential for Cancer Treatment\",\"authors\":\"Amirhossein Rismanbaf\",\"doi\":\"10.18502/igj.v5i1.14065\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"In 2020, around 10 million deaths worldwide were attributed to cancer, making it one of the leading causes of mortality globally. On the other hand, a lot of money, time, and energy is spent on the treatment process of this disease. In fact, cancer is a big challenge that we have been facing for years, but there is still no method that can definitively cure this disease. For years, we have mainly used surgery, chemotherapy, and radiation therapy to treat cancer. Although many advances have been made in these methods, these methods are not a definitive cure for all types of cancer and also have many complications and impose high costs on patients. By virtue of the remarkable effectiveness of CAR-T cell therapy in the treatment of leukemia, hopes for effective treatment for various types of cancer increased, but by testing this method in solid tumors, it was found that this method has low efficiency in solid tumors. In this review article, I consider the challenges and mechanisms that cancer cells apply to resist different main therapies, and finally, by comparing the challenges of different therapies, I conclude that virus therapy has a higher potential than other methods to end the problem of cancer and become a definitive cure for cancer.\",\"PeriodicalId\":406184,\"journal\":{\"name\":\"Immunology and Genetics Journal\",\"volume\":\"6 3\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-11-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Immunology and Genetics Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.18502/igj.v5i1.14065\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immunology and Genetics Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18502/igj.v5i1.14065","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

2020 年,全球约有 1 000 万人死于癌症,癌症已成为导致全球死亡的主要原因之一。另一方面,大量的金钱、时间和精力都花在了这种疾病的治疗过程中。事实上,癌症是我们多年来一直面临的巨大挑战,但至今仍没有一种方法可以彻底治愈这种疾病。多年来,我们主要采用手术、化疗和放疗来治疗癌症。虽然这些方法已经取得了很多进步,但并不能彻底治愈所有类型的癌症,而且还会有很多并发症,给患者带来高昂的费用。由于 CAR-T 细胞疗法在治疗白血病方面的显著疗效,人们对有效治疗各种癌症的希望越来越大,但通过在实体瘤中测试发现,这种方法在实体瘤中的效率很低。在这篇综述文章中,我考虑了癌细胞抵抗不同主要疗法的挑战和机制,最后,通过比较不同疗法的挑战,我得出结论:病毒疗法比其他方法更有可能终结癌症问题,成为癌症的彻底治愈方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Reviewing the Main Cancer Therapies: Virotherapy Has a High Potential for Cancer Treatment
In 2020, around 10 million deaths worldwide were attributed to cancer, making it one of the leading causes of mortality globally. On the other hand, a lot of money, time, and energy is spent on the treatment process of this disease. In fact, cancer is a big challenge that we have been facing for years, but there is still no method that can definitively cure this disease. For years, we have mainly used surgery, chemotherapy, and radiation therapy to treat cancer. Although many advances have been made in these methods, these methods are not a definitive cure for all types of cancer and also have many complications and impose high costs on patients. By virtue of the remarkable effectiveness of CAR-T cell therapy in the treatment of leukemia, hopes for effective treatment for various types of cancer increased, but by testing this method in solid tumors, it was found that this method has low efficiency in solid tumors. In this review article, I consider the challenges and mechanisms that cancer cells apply to resist different main therapies, and finally, by comparing the challenges of different therapies, I conclude that virus therapy has a higher potential than other methods to end the problem of cancer and become a definitive cure for cancer.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信